Skip to content
Screener

Agios Pharmaceuticals AGIO Price / earnings

Price / earnings at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
12.7×-6.6×
Pfizer logo
PfizerPFE
14.7×—
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
28.6×—
Incyte logo
IncyteINCY
14×-1.3×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.4×-7.3×
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
20×-21.5×

Other financials

Income statement

See full
Revenue$44.7M+259%
Gross profit$41.7M+288%
Operating income-$110.6M+13.0%
Net income-$100.7M+10.1%
EPS (diluted)-$1.69+12.4%

Balance sheet

See full
Cash & equivalents$99.6M+23.2%
Total debt$31.2M-36.1%
Total equity$1.0B-25.1%
Total assets$1.1B-24.7%

Cash flow

See full
Operating cash flow-$57.3M+25.7%
CapEx$1.2M+38.5%
Free cash flow-$58.5M+25.0%

Valuation

See full
Market cap$1.93B-5.5%
Enterprise value$1.86B-7.4%
P/S19.6×-30.3×

Profitability

See full
Gross margin92%+3.8pp
Operating margin-466.8%-173pp
Net margin-418.2%—
FCF margin-371.4%-143pp

Returns & leverage

See full
Return on equity-34.3%—
Debt / equity0×0.0×
Current ratio10.2×-4.3×

Where this comes from

Calculated from Agios Pharmaceuticals’s reported figures.

market cap/net income=3.7×

Based on the most recent quarter.

The source filing: Agios Pharmaceuticals’s 10-Q, filed October 31, 2024. Open the filing →

Filed
Oct 31, 2024
Fiscal quarter
Q3 FY2024
Calendar quarter
Q3 2024
Accession
0001439222-24-000138

FAQ

What is Agios Pharmaceuticals's price / earnings?
Agios Pharmaceuticals (AGIO) reported price / earnings of 3.7× in Q3 2024.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about Agios Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude